UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PONY
2326
Pony AI Inc
PONY
$3.12B
| $950K | ﹤0.01% |
136,756
-25,800
| -16% | -$239K |
|
2327
Bristow Group
VTOL
$1.29B
| $946K | ﹤0.01% |
22,905
| – | – |
|
2328
Nokia
NOK
$59.6B
| $943K | ﹤0.01% |
70,985
| – | – |
|
2329
Sinclair Inc
SBGI
$998M
| $939K | ﹤0.01% |
65,875
-875
| -1% | -$12.6K |
|
|
AEVA
2330
Aeva Technologies
AEVA
$1.13B
| $936K | ﹤0.01% |
32,605
+13,746
| +73% | +$271K |
|
2331
Tilray
TLRY
$592M
| $935K | ﹤0.01% |
208,229
+11,894
| +6% | +$68.1K |
|
2332
NovaGold Resources
NG
$3.47B
| $933K | ﹤0.01% |
156,209
+150,989
| +2,893% | +$1.26M |
|
|
EUHY
2333
iShares Euro High Yield Corporate Bond USD Hedged ETF
EUHY
$254M
| $926K | ﹤0.01% |
17,199
| – | – |
|
2334
iShares Expanded Tech-Software Sector ETF
IGV
$13.9B
| $925K | ﹤0.01% |
10,205
-814
| -7% | -$72.4K |
|
2335
Fulgent Genetics
FLGT
$556M
| $924K | ﹤0.01% |
45,020
-56,283
| -56% | -$954K |
|
2336
NIO
NIO
$9.5B
| $918K | ﹤0.01% |
181,351
| – | – |
|
2337
Vanguard FTSE Pacific ETF
VPL
$8.8B
| $915K | ﹤0.01% |
7,906
-12,054
| -60% | -$1.33M |
|
2338
Arvinas
ARVN
$594M
| $914K | ﹤0.01% |
109,966
-1,008
| -0.9% | -$9.4K |
|
2339
Janux Therapeutics
JANX
$1.23B
| $907K | ﹤0.01% |
59,019
-28,738
| -33% | -$416K |
|
2340
Ibotta
IBTA
$773M
| $902K | ﹤0.01% |
26,419
| – | – |
|
2341
Takeda Pharmaceutical
TAK
$58.5B
| $899K | ﹤0.01% |
56,108
| – | – |
|
2342
MetroCity Bankshares
MCBS
$1.02B
| $899K | ﹤0.01% |
25,046
-724
| -3% | -$23.6K |
|
2343
Orrstown Financial Services
ORRF
$831M
| $897K | ﹤0.01% |
21,980
| – | – |
|
2344
Genmab
GMAB
$20.6B
| $896K | ﹤0.01% |
32,612
-32
| -0.1% | -$850 |
|
2345
CorMedix
CRMD
$638M
| $893K | ﹤0.01% |
113,740
-58,142
| -34% | -$459K |
|
2346
Atlanticus Holdings
ATLC
$1.42B
| $892K | ﹤0.01% |
8,726
| – | – |
|
2347
Amphastar Pharmaceuticals
AMPH
$975M
| $889K | ﹤0.01% |
44,062
-11,313
| -20% | -$228K |
|
2348
WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund
DGRS
$404M
| $885K | ﹤0.01% |
14,907
| – | – |
|
2349
Oil-Dri
ODC
$1.25B
| $882K | ﹤0.01% |
8,629
-300
| -3% | -$24K |
|
2350
Elbit Systems
ESLT
$33.2B
| $881K | ﹤0.01% |
1,161
| – | – |
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.